Key Insights

Highlights

No notable highlights available yet

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 7 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

3Total
Not Applicable (1)
Early P 1 (1)
P 2 (1)

Trial Status

Recruiting3
Not Yet Recruiting2
Enrolling By Invitation1
Unknown1

Clinical Trials (7)

Showing 7 of 7 trials
NCT04701749RecruitingPrimary

Study of the Effects of Anticoagulant Interruption Covered by Percutaneous Left Atrial Occlusion in Patients With Chronic Atrial Fibrillation and Radiation Cystitis at Risk of Bleeding

NCT07368647RecruitingPrimary

Chronic Radiation Cystitis and Effect of Hyperbaric Oxygen Therapy on Patient Reported Outcomes and Urine Inflammatory Biomarkers

NCT07259681Not Yet Recruiting

Gut Microbiome in Gynecological Cancer Patients With Pelvic Toxicity: Controls Versus Ozone Treatment. (MicrOzoGineTox)

NCT07125924Not ApplicableNot Yet Recruiting

Intravesical Hyaluronic Acid (HA) for Preventing Radiation Cystitis on Bladder Cancer

NCT07016451Early Phase 1Enrolling By InvitationPrimary

Efficacy of Low-Intensity Shockwave Therapy in Treating Radiation Cystitis

NCT05246774UnknownPrimary

Study of Serum and Urinary Biomarkers and Radiation Cystitis in Patients Treated With Radiotherapy for Localized Prostate Cancer

NCT05245591Phase 2RecruitingPrimary

Radiation Cystitis Treated With Pentosan Polysulfate Sodium Trial

Showing all 7 trials

Research Network

Activity Timeline